SCHEMBL2495239

SCHEMBL2495239

CC(CO)C(CO)CO

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1613788 0.83
SCHEMBL18911476 0.81
SCHEMBL1614947 0.81 TSHR (0.44)
SCHEMBL8972727 0.81 TSHR (0.37)
Nitric Acid SCHEMBL19205888 0.81 CA5A (0.40)
SCHEMBL7912566 0.79
SCHEMBL4754346 0.79
SCHEMBL772803 0.79
SCHEMBL16074686 0.79 TSHR (0.41)
SCHEMBL4383831 0.79

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8030364-B2 Polyols and polyurethanes, polyurethaneforms using the same KIM DO GYUN 2011-10-04 US claimed
US-20090023823-A1 POLYOLS AND POLYURETHANES, POLYURETHANEFORMS USING THE SAME KIM DO GYUN 2009-01-22 US claimed
WO-2006080743-A1 POLYOLS AND POLYURETHANES, POLYURETHANEFORMS USING THE SAME KIM DO GYUN (KR) 2006-08-03 WO claimed
WO-2017214282-A1 ANTI-EGFR ANTIBODY DRUG CONJUGATES ABBVIE INC. (US) 2017-12-14 WO disclosed
WO-2017214335-A1 ANTI-B7-H3 ANTIBODIES AND ANTIBODY DRUG CONJUGATES ABBVIE INC. (US) 2017-12-14 WO disclosed
WO-2017214462-A2 ANTI-CD98 ANTIBODIES AND ANTIBODY DRUG CONJUGATES ABBVIE INC. (US) 2017-12-14 WO disclosed
US-20170298058-A1 HETEROCYCLIC RING AND CARBOCYCLIC DERIVATIVE SHIONOGI & CO (JP) 2017-10-19 US disclosed
US-9550763-B2 Heterocyclic ring and carbocyclic derivative SHIONOGI & CO., LTD. (JP) 2017-01-24 US disclosed
US-20160339117-A1 BCL-XL Inhibitory Compounds Having Low Cell Permeability and Antibody Drug Conjugates Including the Same ABBVIE INC. (US) 2016-11-24 US disclosed
WO-2016094509-A1 BCL XL INHIBITORY COMPOUNDS HAVING LOW CELL PERMEABILITY AND ANTIBODY DRUG CONJUGATES INCLUDING THE SAME ABBVIE INC. (US) 2016-06-16 WO disclosed
US-8440281-B2 Stabilized blends of polyester and polyamide BASF SE (DE) 2013-05-14 US disclosed
US-20100233405-A1 Stabilized Blends of Polyester and Polyamide CIBA CORPORATION (US) 2010-09-16 US disclosed
EP-0225347-B1 POLYESTER YARN AND METHOD FOR PREPARING IT RHONE-POULENC VISCOSUISSE SA (CH) 1992-08-26 EP disclosed
EP-0459592-A2 Modified epoxy resin composition SHELL INTERNATIONALE RESEARCHMAATSCHAPPIJ B.V. (NL) 1991-12-04 EP disclosed
EP-0281213-A2 Process for the preparation of a modified epoxy resin SHELL INTERNATIONALE RESEARCHMAATSCHAPPIJ B.V. (NL) 1988-09-07 EP disclosed
EP-0225347-A1 POLYESTER YARN AND METHOD FOR PREPARING IT. SCHWEIZERISCHE VISCOSE (CH) 1987-06-16 EP disclosed
WO-1986007616-A1 METHOD FOR PREPARING MODIFIED POLYESTER YARNS AND POLYESTER YARN OBTAINED THEREBY VISCOSUISSE SA (CH) 1986-12-31 WO disclosed
EP-0017207-A1 Stable aqueous or hydro-alcoholic solutions of fat-soluble perfume oils Henkel Kommanditgesellschaft auf Aktien (DE) 1980-10-15 EP disclosed
US-4145461-A Process of warp sizing which uses a low molecular weight polyester and chelated titanate in a water dispersion STANDARD OIL COMPANY (INDIANA) (US) 1979-03-20 US disclosed
US-4036819-A FROM CHLORINATED AROMATIC DICARBOXYLIC ACID DYNAMIT NOBEL AKTIENGESELLSCHAFT (DT) 1977-07-19 US disclosed